- Home
- ALUR vs PRTG Comparison
ALUR vs PRTG Comparison
Compare ALUR & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALUR
- PRTG
- Stock Information
- Founded
- ALUR 2009
- PRTG 1973
- Country
- ALUR United States
- PRTG British Virgin Islands
- Employees
- ALUR N/A
- PRTG N/A
- Industry
- ALUR
- PRTG Oil & Gas Production
- Sector
- ALUR
- PRTG Energy
- Exchange
- ALUR Nasdaq
- PRTG Nasdaq
- Market Cap
- ALUR 18.0M
- PRTG 17.7M
- IPO Year
- ALUR N/A
- PRTG N/A
- Fundamental
- Price
- ALUR $2.45
- PRTG $5.89
- Analyst Decision
- ALUR Strong Buy
- PRTG
- Analyst Count
- ALUR 3
- PRTG 0
- Target Price
- ALUR $22.83
- PRTG N/A
- AVG Volume (30 Days)
- ALUR 71.0K
- PRTG 237.7K
- Earning Date
- ALUR 08-12-2025
- PRTG 08-26-2025
- Dividend Yield
- ALUR N/A
- PRTG N/A
- EPS Growth
- ALUR N/A
- PRTG N/A
- EPS
- ALUR N/A
- PRTG N/A
- Revenue
- ALUR $28,304,000.00
- PRTG N/A
- Revenue This Year
- ALUR N/A
- PRTG N/A
- Revenue Next Year
- ALUR $49.37
- PRTG N/A
- P/E Ratio
- ALUR N/A
- PRTG N/A
- Revenue Growth
- ALUR N/A
- PRTG N/A
- 52 Week Low
- ALUR $2.15
- PRTG $2.10
- 52 Week High
- ALUR $33.75
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- ALUR 47.19
- PRTG 41.51
- Support Level
- ALUR $2.38
- PRTG $5.32
- Resistance Level
- ALUR $2.54
- PRTG $6.00
- Average True Range (ATR)
- ALUR 0.13
- PRTG 0.68
- MACD
- ALUR -0.00
- PRTG -0.01
- Stochastic Oscillator
- ALUR 42.08
- PRTG 22.33
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.